TSCI starts proprietary production in the Netherlands

TSCI, a subsidiary of TSC Group, starts today the new fully automated production line for its patented warming  blankets. The new production technology provides TSCI a significant cost advantage and additional capacity over the current production in the United States.

TSCI was created 10 years ago and belongs now to the top 5 players in the global market for patient temperature management with proprietary products. TSCI brings innovation to the forced air hypothermia application in hospitals with an extensive range of warming blankets. Forced air therapy is a standard of care in fighting hypothermia. Before, during and after the surgical intervention, TSCI 's blankets assist in keeping patients normothermic and stable.

Strategique supported TSCI in the decision to invest over € 5 million in the new production technology and in the execution of the investment. In the initial phase in 2011 Strategique assessed the risks and benefits of the considered investment, using among others game theory to anticipate competitive reactions. Subsequently the negotiations with the main supplier were coordinated. Parallel Strategique arranged the 100% debt financing of the investment with an overall renewal of banking facilities. After considering different production structures a search was set up for a production partner and subsequently a production alliance was construed with Helvoet. In the last phase we assisted TSCI with the extension of its distribution network and an alliance in the United States.

TSC Group and Strategique have a long standing relation since the start of TSC in 1993, which was facilitated out of Strategique’s offices in Helvoirt. Since that time several projects and engagements followed as the merger in The Netherlands and acquisitions in France.